This is how the EU & Dutch government can achieve equal access to medicines

Why are (some) medicines so expensive? How are medicines developed in the Netherlands, and how does this system contribute to unequal access to medicines? In our new infographic we explain how the system works and why we think the EU and Dutch government can do more to ensure equal access to medicines for society.

In recent years, the prices of some (new) medicines have soared, jeopardizing access to these medicines for those who need them. These high prices are (in part) due to issues like the lack of transparency on Research & Development costs and market exclusivity of pharmaceutical companies. In addition, there is no transparency on prices of medicines between (EU) countries. As a result, there is either no, or unequal access to medicines due to these high prices. Or, if there is access after all, via medical insurance, this comes at a high cost for society.


Infographic: The system of medicine development


In the infographic Wemos also shows what the EU and the Netherlands can do to ensure equal access to medicines for their citizens. Global health advocate Ella Weggen: ‘They could adopt laws to ensure transparency on R&D costs and prices and ensure healthy competition and prevent anti-competitive behavior. Also they should attach conditions to licenses on medicines that are developed with public money. Finally, better and transparent cooperation between countries in negotiations on medicine prices is required.’


Read more about our medicines programme

Come and join us on May 16th in de Rode Hoed – Farma’s Other Futures (Dutch)

Head over to our knowledge platform for more Wemos infographics and other materials


Tags: ,

Recent News items

This was the year 2019: our highlights


What an eventful year it has been. 2019 was filled with collaborations, workshops, new publications, media moments, and mutual learning sessions. And it was the anniversary year in which we looked back on 40 years of our work in protecting global public health. We’re ready for 2020!

Continue reading

sustainable development goals

How healthy is a ‘healthy’ economy? A closer look into SDG goals


To realise the Sustainable Development Goals (SDGs) everywhere, governments should abandon Gross Domestic Product (GDP) growth as a policy objective and place more emphasis on SDG17 on global co-operation. That is one of the main conclusions of the paper ‘ ‘How healthy is a ‘healthy economy’? Incompatibility between current pathways towards SDG3 and SDG8’ by Wemos’ global health advocates Mariska Meurs, Lisa Seidelmann and Myria Koutsoumpa, published today in the academic journal Globalization & Health.

Continue reading